BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 19513816)

  • 1. Aberrant promoter methylation and reduced expression of p16 gene in esophageal squamous cell carcinoma from Kashmir valley: a high-risk area.
    Salam I; Hussain S; Mir MM; Dar NA; Abdullah S; Siddiqi MA; Lone RA; Zargar SA; Sharma S; Hedau S; Basir SF; Bharti AC; Das BC
    Mol Cell Biochem; 2009 Dec; 332(1-2):51-8. PubMed ID: 19513816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p16 gene silencing along with p53 single-nucleotide polymorphism and risk of esophageal cancer in Northeast India.
    Das M; Sharma SK; Sekhon GS; Mahanta J; Phukan RK; Jalan BK
    Tumour Biol; 2017 May; 39(5):1010428317698384. PubMed ID: 28459370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation-mediated gene silencing of suppressor of cytokine signaling-1 (SOCS-1) gene in esophageal squamous cell carcinoma patients of Kashmir valley.
    Hussain S; Singh N; Salam I; Bandil K; Yuvaraj M; Akbar Bhat M; Muzaffar Mir M; Siddiqi MA; Sobti RC; Bharadwaj M; Das BC
    J Recept Signal Transduct Res; 2011 Apr; 31(2):147-56. PubMed ID: 21385099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular detection of p16 promoter methylation in the serum of patients with esophageal squamous cell carcinoma.
    Hibi K; Taguchi M; Nakayama H; Takase T; Kasai Y; Ito K; Akiyama S; Nakao A
    Clin Cancer Res; 2001 Oct; 7(10):3135-8. PubMed ID: 11595706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Methylation of p16 and hMLH1 genes in esophageal squamous cell carcinoma and reflux esophagitis].
    Wang F; Xie XJ; Piao YS; Liu B; Wang LD
    Zhonghua Bing Li Xue Za Zhi; 2011 Aug; 40(8):537-41. PubMed ID: 22169643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p16INK4a hypermethylation and p53, p16 and MDM2 protein expression in esophageal squamous cell carcinoma.
    Taghavi N; Biramijamal F; Sotoudeh M; Khademi H; Malekzadeh R; Moaven O; Memar B; A'rabi A; Abbaszadegan MR
    BMC Cancer; 2010 Apr; 10():138. PubMed ID: 20388212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation of RASSF1A gene promoter and the correlation with DNMT1 expression that may contribute to esophageal squamous cell carcinoma.
    Du Z; Ma K; Sun X; Li A; Wang H; Zhang L; Lin F; Feng X; Song J
    World J Surg Oncol; 2015 Apr; 13():141. PubMed ID: 25886188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of roasting meat intake with the risk of esophageal squamous cell carcinoma of Kazakh Chinese via affecting promoter methylation of p16 gene.
    Chen W; Yang C; Yang L; Qi C; Tian S; Han Y; Dou Y; Ma Y; Tian D; Zheng Y
    Asia Pac J Clin Nutr; 2014; 23(3):488-97. PubMed ID: 25164462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation and loss of protein expression in esophageal squamous cell carcinogenesis of high-risk area.
    Guo XQ; Wang SJ; Zhang LW; Wang XL; Zhang JH; Guo W
    J Exp Clin Cancer Res; 2007 Dec; 26(4):587-94. PubMed ID: 18365557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter methylation‑associated silencing of p27kip1 gene with metastasis in esophageal squamous cell carcinoma.
    Ling Y; Zhang C; Xu Y; Zhu J; Zhu C; Lu M; Liu Y; Zhou T
    Mol Med Rep; 2014 Mar; 9(3):1075-9. PubMed ID: 24402707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modes of silencing of p16 in development of esophageal squamous cell carcinoma.
    Tokugawa T; Sugihara H; Tani T; Hattori T
    Cancer Res; 2002 Sep; 62(17):4938-44. PubMed ID: 12208744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant promoter methylation of the TPEF gene in esophageal squamous cell carcinoma.
    Zhao BJ; Tan SN; Cui Y; Sun DG; Ma X
    Dis Esophagus; 2008; 21(7):582-8. PubMed ID: 19040536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant p16 methylation, a possible epigenetic risk factor in familial esophageal squamous cell carcinoma.
    Abbaszadegan MR; Raziee HR; Ghafarzadegan K; Shakeri MT; Afsharnezhad S; Ghavamnasiry MR
    Int J Gastrointest Cancer; 2005; 36(1):47-54. PubMed ID: 16227635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter hypermethylation and quantitative expression analysis of CDKN2A (p14ARF and p16INK4a) gene in esophageal squamous cell carcinoma.
    Ito S; Ohga T; Saeki H; Watanabe M; Kakeji Y; Morita M; Yamada T; Maehara Y
    Anticancer Res; 2007; 27(5A):3345-53. PubMed ID: 17970080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study on RIZ1 gene promoter methylation status in human esophageal squamous cell carcinoma.
    Dong SW; Zhang P; Liu YM; Cui YT; Wang S; Liang SJ; He Z; Sun P; Wang YG
    World J Gastroenterol; 2012 Feb; 18(6):576-82. PubMed ID: 22363126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypermethylation of p16 gene promoter correlates with loss of p16 expression that results in poorer prognosis in esophageal squamous cell carcinomas.
    Fujiwara S; Noguchi T; Takeno S; Kimura Y; Fumoto S; Kawahara K
    Dis Esophagus; 2008; 21(2):125-31. PubMed ID: 18269647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [DNA methylation status of RARβ2 and p16(INK4α) in peripheral blood and tumor tissue in patients with esophageal squamous cell carcinoma].
    Wang CC; Mao WM; Ling ZQ
    Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):441-5. PubMed ID: 22967446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ analysis of p16/INK4 promoter hypermethylation in esophageal carcinoma and gastric carcinoma.
    Zhang F; Wang L; Wu PP; Yan ZW; Zheng L; Yu YY; Jiang XC
    Chin J Dig Dis; 2004; 5(4):149-55. PubMed ID: 15612883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
    Tanaka K; Imoto I; Inoue J; Kozaki K; Tsuda H; Shimada Y; Aiko S; Yoshizumi Y; Iwai T; Kawano T; Inazawa J
    Oncogene; 2007 Sep; 26(44):6456-68. PubMed ID: 17438526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Status of p16(INK4a) and E-cadherin gene promoter methylation in Moroccan patients with cervical carcinoma.
    Attaleb M; El hamadani W; Khyatti M; Benbacer L; Benchekroun N; Benider A; Amrani M; El Mzibri M
    Oncol Res; 2009; 18(4):185-92. PubMed ID: 20112504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.